These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19303679

  • 1. Rapamycin for focal segmental glomerulosclerosis: a report of 3 cases.
    Tsagalis G, Psimenou E, Iliadis A, Nakopoulou L, Laggouranis A.
    Am J Kidney Dis; 2009 Aug; 54(2):340-4. PubMed ID: 19303679
    [Abstract] [Full Text] [Related]

  • 2. Unusual post-transplantation recurrence of focal segmental glomerulosclerosis which resolved with cyclosporine but not with sirolimus.
    Skhiri H, Morelon E, Noel LH, Mamzer-Bruneel MF, Legendre C, Peraldi MN, Kreis H.
    Transpl Int; 2005 Apr; 18(4):458-60. PubMed ID: 15773967
    [Abstract] [Full Text] [Related]

  • 3. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
    Shishido S, Satou H, Muramatsu M, Hamasaki Y, Ishikura K, Hataya H, Honda M, Asanuma H, Aikawa A.
    Clin Transplant; 2013 Apr; 27(2):E143-50. PubMed ID: 23383697
    [Abstract] [Full Text] [Related]

  • 4. Treatment of corticoresistant idiopathic nephrotic syndrome in the adult: minimal change disease and focal segmental glomerulosclerosis.
    Meyrier A, Simon P.
    Adv Nephrol Necker Hosp; 1988 Apr; 17():127-50. PubMed ID: 3124536
    [Abstract] [Full Text] [Related]

  • 5. A prospective, open-label trial of sirolimus in the treatment of focal segmental glomerulosclerosis.
    Tumlin JA, Miller D, Near M, Selvaraj S, Hennigar R, Guasch A.
    Clin J Am Soc Nephrol; 2006 Jan; 1(1):109-16. PubMed ID: 17699197
    [Abstract] [Full Text] [Related]

  • 6. Primum non nocere: Should adults with idiopathic FSGS receive steroids?
    Franceschini N, Hogan SL, Falk RJ.
    Semin Nephrol; 2003 Mar; 23(2):229-33. PubMed ID: 12704583
    [Abstract] [Full Text] [Related]

  • 7. [Choosing the right treatment approach in focal and segmental glomerular sclerosis with chronic renal failure].
    Valerio F, Sottini L, Turina S, Dallera N, Faberi E, Kenou R, Mazzola G, Scolari F.
    G Ital Nefrol; 2008 Mar; 25 Suppl 44():S88-S98. PubMed ID: 19048592
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis.
    Korbet SM.
    Semin Nephrol; 2003 Mar; 23(2):219-28. PubMed ID: 12704582
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis.
    Cattran DC.
    Semin Nephrol; 2003 Mar; 23(2):234-41. PubMed ID: 12704584
    [Abstract] [Full Text] [Related]

  • 10. A case report of nephrotic syndrome due to collapsing focal segmental glomerulosclerosis treated with low-density lipoprotein apheresis.
    Miyazono M, Tomiyoshi Y, Kishi T, Ikeda Y, Sakemi T, Sanai T, Node K.
    Ther Apher Dial; 2008 Aug; 12(4):333-6. PubMed ID: 18789122
    [Abstract] [Full Text] [Related]

  • 11. Alternative treatments for focal and segmental glomerular sclerosis.
    Ponticelli C, Passerini P.
    Clin Nephrol; 2001 May; 55(5):345-8. PubMed ID: 11393378
    [Abstract] [Full Text] [Related]

  • 12. Recurrence of focal segmental glomerulosclerosis after renal transplantation: a case report.
    Akash N.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):91-4. PubMed ID: 17237899
    [Abstract] [Full Text] [Related]

  • 13. Treatment practices of FSGS among North American pediatric nephrologists.
    Vehaskari VM.
    Pediatr Nephrol; 1999 May; 13(4):301-3. PubMed ID: 10454778
    [Abstract] [Full Text] [Related]

  • 14. Late conversion to everolimus complicated with necrotizing glomerulonephritis in a renal allograft recipient: case report.
    Nowacka-Cieciura E, Perkowska-Ptasińska A, Sulikowska-Rowińska A, Cieciura T, Wazna E, Durlik M.
    Transplant Proc; 2009 May; 41(1):441-5. PubMed ID: 19249576
    [Abstract] [Full Text] [Related]

  • 15. Immunosuppressive treatment in primary focal segmental glomerulosclerosis.
    Xu S, Xu G, Zeng L.
    J Nephrol; 2012 May; 25(5):626-35. PubMed ID: 22344540
    [Abstract] [Full Text] [Related]

  • 16. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP, van de Kar NC, Wetzels JF.
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [Abstract] [Full Text] [Related]

  • 17. Consideration of vaccination against the FSGS factor.
    Altschuler EL.
    Med Hypotheses; 2001 Dec; 57(6):703-4. PubMed ID: 11918430
    [Abstract] [Full Text] [Related]

  • 18. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.
    Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD.
    Transplantation; 2009 Apr 27; 87(8):1232-9. PubMed ID: 19384172
    [Abstract] [Full Text] [Related]

  • 19. [Primary focal segmental glomerulosclerosis in adults: response to treatment and outcome].
    Niang A, Hachim K, Zahiri K, Fatihi E, Benghanem M, Ramdani B, Sqalli S, Zaid D.
    Dakar Med; 2004 Apr 27; 49(1):13-6. PubMed ID: 15782470
    [Abstract] [Full Text] [Related]

  • 20. Plasma exchange and tacrolimus therapy for focal segmental glomerulosclerosis collapsing variant and the cytokine dynamics: a case report.
    Kanai T, Shiraishi H, Ito T, Odaka J, Saito T, Aoyagi J, Ueda Y, Momoi MY.
    Ther Apher Dial; 2010 Dec 27; 14(6):603-5. PubMed ID: 21118370
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.